Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: A case series and literature review
Leukemia Research, 06/22/2012
Clinical Article
Thorpe M et al. – AZA treatment was well–tolerated and associated with a significant response rate in all forms of the disease.



